Off-brand versions of Lilly weight loss drug must be pulled off market, could mean higher ...
The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...
FDA approves generic in same class as Ozempic for diabetes. Could it ease shortage, price?
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
There’s still no generic Ozempic, but a lower-priced daily injected GLP-1 is coming
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...
FDA says knockoff versions of Lilly obesity drug must come off the market
The federal government is phasing out off-brand copies of two blockbuster drugs used to treat obesity and diabetes.
The Zepbound Shortage Is Over — Here's What to Expect if You've Been Using an Off-Brand ...
Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...
The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see ...
The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...
Potential 'fungal contamination' leads to nationwide recall of popular brand of eye drops: FDA
A popular brand of eye drops is being recalled nationwide after a consumer reported a "foreign material" was found in a ...
ScienceAlert on MSN1 天
World's Most Common Pain Relief Drug May Induce Risky Behavior
A cetaminophen, also known as paracetamol and sold widely under the brand names Tylenol and Panadol, may also increase ...
Medscape2 天
Obesity Drug Zepbound Approved for Obstructive Sleep Apnea
The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...
Mushrooms, pizza and more items recalled by the FDA. Here's the list for December 2024
FDA receives reports almost daily from different food companies regarding potential allergens or foodborne illnesses.
IFLScience on MSN3 天
FDA Breakthrough Therapy Designation Granted For Promising Rectal Cancer Drug
T he US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to a cancer drug called dostarlimab ...